147 related articles for article (PubMed ID: 1465814)
1. Living-unrelated renal transplantation.
Simforoosh N; Bassiri A; Amiransari B; Gol S
Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
[No Abstract] [Full Text] [Related]
2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
3. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
[No Abstract] [Full Text] [Related]
4. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
[No Abstract] [Full Text] [Related]
5. Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
[No Abstract] [Full Text] [Related]
6. Cyclosporine-related hypercoagulability: fact or fiction?
Edwards CM; Morgan JD; Donnelly PK
Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
[No Abstract] [Full Text] [Related]
7. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
[No Abstract] [Full Text] [Related]
8. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
[No Abstract] [Full Text] [Related]
9. Postoperative endogenous serum cortisol level as indicator of the immunosuppressive efficacy of prednisolone in kidney allograft recipients.
Kaden J; Egerer K; May G; Schreiner S; Wesslau C; Schönemann C; Egerer B
Transplant Proc; 1992 Dec; 24(6):2622-3. PubMed ID: 1465888
[No Abstract] [Full Text] [Related]
10. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
11. DR6 compatibility and kidney graft survival.
Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
[No Abstract] [Full Text] [Related]
12. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
Park K; Kim YS; Kim SI
Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
[No Abstract] [Full Text] [Related]
13. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
14. Kidney transplantation in Slovenia from 1986 through 1991.
Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
[No Abstract] [Full Text] [Related]
15. Low-dose OKT3 for cadaveric renal transplantation.
Schweizer RT; Roper L; Hull D; Bartus SA
Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
[No Abstract] [Full Text] [Related]
16. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
[No Abstract] [Full Text] [Related]
17. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
[No Abstract] [Full Text] [Related]
18. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
[TBL] [Abstract][Full Text] [Related]
19. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
Berthoux FC; Guerin C; Burgard G; Berthoux P; Alamartine E
Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
[No Abstract] [Full Text] [Related]
20. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
